Metropolitan Life Insurance Company (MetLife)’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,730
| Closed | -$474K | – | 668 |
|
|
2024
Q1 | $474K | Sell |
4,730
-95
| -2% | -$8.36K | 0.02% | 485 |
|
|
2023
Q4 | $433K | Sell |
4,825
-79
| -2% | -$6.3K | 0.02% | 490 |
|
|
2023
Q3 | $376K | Sell |
4,904
-288
| -6% | -$23.9K | 0.02% | 497 |
|
|
2023
Q2 | $435K | Sell |
5,192
-120
| -2% | -$9.76K | 0.02% | 483 |
|
|
2023
Q1 | $448K | Sell |
5,312
-1,627
| -23% | -$140K | 0.02% | 483 |
|
|
2022
Q4 | $565K | Sell |
6,939
-370
| -5% | -$29.8K | 0.03% | 470 |
|
|
2022
Q3 | $519K | Sell |
7,309
-452
| -6% | -$40.6K | 0.02% | 479 |
|
|
2022
Q2 | $697K | Sell |
7,761
-199
| -3% | -$20.6K | 0.03% | 448 |
|
|
2022
Q1 | $892K | Sell |
7,960
-7,395
| -48% | -$867K | 0.03% | 443 |
|
|
2021
Q4 | $1.86M | Sell |
15,355
-613
| -4% | -$68.2K | 0.03% | 574 |
|
|
2021
Q3 | $1.61M | Sell |
15,968
-616
| -4% | -$68K | 0.02% | 628 |
|
|
2021
Q2 | $1.94M | Sell |
16,584
-189
| -1% | -$22.7K | 0.03% | 540 |
|
|
2021
Q1 | $1.85M | Sell |
16,773
-785
| -4% | -$85.2K | 0.03% | 558 |
|
|
2020
Q4 | $1.76M | Sell |
17,558
-921
| -5% | -$85.4K | 0.03% | 538 |
|
|
2020
Q3 | $1.44M | Sell |
18,479
-883
| -5% | -$66.5K | 0.02% | 554 |
|
|
2020
Q2 | $1.35M | Sell |
19,362
-1,225
| -6% | -$77.2K | 0.02% | 573 |
|
|
2020
Q1 | $959K | Sell |
20,587
-79
| -0.4% | -$5.07K | 0.02% | 695 |
|
|
2019
Q4 | $1.64M | Buy |
20,666
+130
| +0.6% | +$10K | 0.03% | 644 |
|
|
2019
Q3 | $1.52M | Sell |
20,536
-203
| -1% | -$14.6K | 0.03% | 643 |
|
|
2019
Q2 | $1.61M | Buy |
20,739
+1,348
| +7% | +$102K | 0.03% | 627 |
|
|
2019
Q1 | $1.47M | Sell |
19,391
-769
| -4% | -$61.1K | 0.03% | 658 |
|
|
2018
Q4 | $1.47M | Sell |
20,160
-438
| -2% | -$34.9K | 0.03% | 591 |
|
|
2018
Q3 | $1.97M | Sell |
20,598
-998
| -5% | -$99K | 0.03% | 540 |
|
|
2018
Q2 | $2.16M | Sell |
21,596
-699
| -3% | -$73.8K | 0.04% | 470 |
|
|
2018
Q1 | $2.35M | Sell |
22,295
-23
| -0.1% | -$2.33K | 0.03% | 436 |
|
|
2017
Q4 | $2.07M | Sell |
22,318
-46,497
| -68% | -$4.22M | 0.03% | 525 |
|
|
2017
Q3 | $6.23M | Sell |
68,815
-1,888
| -3% | -$161K | 0.04% | 451 |
|
|
2017
Q2 | $5.94M | Sell |
70,703
-2,253
| -3% | -$182K | 0.04% | 468 |
|
|
2017
Q1 | $5.89M | Sell |
72,956
-1,259
| -2% | -$99K | 0.04% | 480 |
|
|
2016
Q4 | $5.58M | Sell |
74,215
-2,263
| -3% | -$163K | 0.04% | 498 |
|
|
2016
Q3 | $5.18M | Sell |
76,478
-1,002
| -1% | -$67.2K | 0.04% | 510 |
|
|
2016
Q2 | $5.26M | Sell |
77,480
-2,093
| -3% | -$154K | 0.04% | 498 |
|
|
2016
Q1 | $5.75M | Sell |
79,573
-2,049
| -3% | -$134K | 0.04% | 438 |
|
|
2015
Q4 | $5.51M | Sell |
81,622
-1,378
| -2% | -$96.4K | 0.04% | 453 |
|
|
2015
Q3 | $5.37M | Sell |
83,000
-1,642
| -2% | -$121K | 0.04% | 471 |
|
|
2015
Q2 | $6.92M | Sell |
84,642
-4,425
| -5% | -$341K | 0.05% | 388 |
|
|
2015
Q1 | $6.17M | Sell |
89,067
-1,018
| -1% | -$73.5K | 0.05% | 431 |
|
|
2014
Q4 | $6.83M | Buy |
90,085
+1,483
| +2% | +$117K | 0.05% | 386 |
|
|
2014
Q3 | $7.17M | Sell |
88,602
-2,019
| -2% | -$169K | 0.05% | 359 |
|
|
2014
Q2 | $7.92M | Sell |
90,621
-6,329
| -7% | -$550K | 0.05% | 354 |
|
|
2014
Q1 | $8.36M | Sell |
96,950
-2,330
| -2% | -$191K | 0.06% | 346 |
|
|
2013
Q4 | $8.01M | Sell |
99,280
-2,108
| -2% | -$164K | 0.06% | 346 |
|
|
2013
Q3 | $7.9M | Sell |
101,388
-1,273
| -1% | -$98K | 0.06% | 336 |
|
|
2013
Q2 | $7.19M | Buy |
+102,661
| New | +$7.16M | 0.06% | 343 |
|
Other funds holding EMN
Metropolitan Life Insurance Company (MetLife)'s EMN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Eastman Chemical (EMN) in Q2 2024, closing a stake of 4,730 shares — an estimated $474K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EMN in Q2 2013 and held it in 44 quarters. The position peaked at $8.36M in Q1 2014. 752 funds tracked by Wall St. Rank hold EMN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Eastman Chemical position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,730 Eastman Chemical shares in Q2 2024, an estimated $474K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Eastman Chemical in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Eastman Chemical position peaked at $8.36M in Q1 2014.
- 752 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.